
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for EXPO and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for EXPO and 80,000+ other tickers.
See exactly how EXPO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for EXPO and 80,000+ other tickers.
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics…

MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2026 financial results for the period ended July 3, 2026 following the close of the market on Thursday, July 30, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.

Exponent Inc. receives a buy rating, driven by its expert consulting model in high-stakes, complex technical domains. EXPO's value proposition lies in its deep technical talent, critical for problems where failure is costly and regulatory scrutiny is high. The AI debate is a catalyst: rising complexity in physical systems should increase demand for EXPO's services, not diminish it.

Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy

MENLO PARK, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson will participate in a fireside chat at the following investor conference:

Exponent is a market leader in scientific and engineering consulting, boasting a 13-year dividend growth streak and a fortress balance sheet. EXPO's fiscal 2026 outlook signals rising top and bottom lines, with AI-related demand driving proactive and reactive service growth. The stock trades at ~26.5x FY26E EPS, well below its 5-year average, suggesting undervaluation with a fair value estimate of $73.80 versus a ~$65 share price.